Buy Piramal Enterprises, target Rs 2,350: Kunal Bothra
Buy Piramal Enterprises Ltd. at a price target of Rs 2350.0 and a stoploss at Rs 2180 from entry point.

Piramal Enterprises Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 1738.64 Crore to Sales Value (52.73 % of Total Sales), Interest which contributed Rs 1103.73 Crore to Sales Value (33.47 % of Total Sales), Sale of services which contributed Rs 247.66 Crore to Sales Value (7.51 % of Total Sales), Income From Financial Services which contributed Rs 104.06 Crore to Sales Value (3.15 % of Total Sales), Dividend which contributed Rs 51.26 Crore to Sales Value (1.55 % of Total Sales), Other Operating Revenue which contributed Rs 50.43 Crore to Sales Value (1.52 % of Total Sales) and Processing Charges which contributed Rs 1.17 Crore to Sales Value (0.03 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 31-12-2018, the company has reported a Consolidated sales of Rs 3489.08 Crore, up 10.97 % from last quarter Sales of Rs 3144.10 Crore and up 22.07 % from last year same quarter Sales of Rs 2858.36 Crore Company has reported net profit after tax of Rs 535.64 Crore in latest quarter. The company’s top management includes Dr.R A Mashelkar, Dr.(Mrs.)Swati Piramal, Mr.Ajay Piramal, Mr.Anand Piramal, Mr.Deepak M Satwalekar, Mr.Gautam Banerjee, Mr.Keki Dadiseth, Mr.Narayanan Vaghul, Mr.S Ramadorai, Mr.Siddharth Mehta, Mr.Vijay Shah, Ms.Arundhati Bhattacharya, Ms.Nandini Piramal, Prof.Goverdhan Mehta. Company has Deloitte Haskins & Sells LLP as its auditoRs As on 31-12-2018, the company has a total of 183,412,258 shares outstanding.
Download ET Markets APP